Showing results (71-80 of 399) with videos related to
Sort By:
Pageof 40
Journal of Oncology Practice|August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical centerBrett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.Blood Reviews|February 22, 2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDSStacey M Frumm, Shai Shimony, Richard M Stone, et al.Journal of Hematology & Oncology|December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewJorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.Biorxiv : the Preprint Server for Biology|January 27, 2025
Myofibroblasts reduce angiogenesis and vasculogenesis in a vascularized microphysiological model of lung fibrosisElena Cambria, Adriana Blazeski, Eunkyung Clare Ko, et al.Current Medical Research and Opinion|October 31, 2014
One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparisonJames E Signorovitch, Keith A Betts, William M Reichmann, et al.Molecular and Cellular Biology|January 1, 2004
Nuclear reorganization of mammalian DNA synthesis prior to cell cycle exitDavid A Barbie, Brian A Kudlow, Richard Frock, et al.Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTHJeffrey I Zwicker, Tzu-Fei Wang, Daniel J DeAngelo, et al.Blood Cancer Journal|December 20, 2023
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemiaAndrew Hantel, Colin Cernik, Hajime Uno, et al.The Oncologist|August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer CentersAndrew Hantel, Eric C Blackstone, Anna C Revette, et al.Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.Pageof 40